DNA Immunization with CTLA-4 Fusion Enhances Immune Response Against Hepatitis B Virus
Author Information
Author(s): Yin Ying, Wu Chunchen, Song Jingjiao, Wang Junzhong, Zhang Ejuan, Liu Hongyan, Yang Dongliang, Chen Xinwen, Lu Mengji, Xu Yang
Primary Institution: Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Hypothesis
How does the Th1/Th2 bias of primed immune responses by a DNA vaccine influence hepatitis B virus (HBV) clearance?
Conclusion
Viral clearance could be efficiently achieved by a Th1/Th2-balanced immune response, with a small but significant shift in T-cell and B-cell immune responses.
Supporting Evidence
- Immunizations with pCTLA-4-HBc and pHBc cleared HBsAg significantly faster than control mice.
- All immunized mice except one were negative for HBsAg at day 10.
- HBV DNA concentrations in the serum samples of mice were below the detection limit of quantitative PCR.
Takeaway
The study shows that a special type of vaccine can help the body fight off a virus called hepatitis B faster by making the immune system work better.
Methodology
Mice were immunized with different DNA plasmids and then challenged with HBV to monitor immune responses and viral clearance.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
Female BALB/cJ mice, 6 weeks of age.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website